Effects of Empagliflozin on Symptoms, Physical Limitations and Quality of Life in Patients Hospitalized for Acute Heart Failure - Results From the EMPULSE Trial (2022)
Artigo em Revista Científica Internacional
Kosiborod, MN; Angermann, CE; Collins, SP; Teerlink, JR; Ponikowski, P; Biegus, J; Comin-Colet, J; Ferreira, JP; Mentz, RJ; Nassif, ME; Psotka, MA; Tromp, J; Brueckmann, M; Blatchford, JP; Salsali, A; Voors, AA

Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization (2022)
Artigo em Revista Científica Internacional
Henry, A; Gordillo-Maranon, M; Finan, C; Schmidt, AF; Ferreira, JP; Karra, R; Sundstrom, J; Lind, L; Arnlov, J; Zannad, F; Malarstig, A; Hingorani, AD; Lumbers, RT

Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial (2022)
Artigo em Revista Científica Internacional
Butler, J; Filippatos, G; Siddiqi, TJ; Brueckmann, M; Bohm, M; Chopra, VK; Ferreira, JP; Januzzi, JL; Kaul, S; Pina, IL; Ponikowski, P; Shah, SJ; Senni, M; Vedin, O; Verma, S; Peil, B; Pocock, SJ; Zannad, F; Packer, M; Anker, SD

Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status (2021)
Artigo em Revista Científica Internacional
Anker, SD; Butler, J; Filippatos, G; Khan, MS; Marx, N; Lam, CS; Schnaidt, S; Ofstad, AP; Brueckmann, M; Jamal, W; Bocchi, EA; Ponikowski, P; Perrone, SV; Januzzi, JL; Verma, S; Böhm, M; Ferreira, JP; Pocock, SJ; Zannad, F; Packer, M